Long-term low-grade inflammatory response and abnormal activation of the immune system are closely linked to the development of T2DM, and the elevated concentrations of systemic inflammatory markers (IL-1β and IL-6) are risk factors for complications of T2DM [24]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.